Haemonetics Corporation
Medical Devices
Healthcare
HAE
48.35 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
51.11
52 week high
93.38
high
51.96
52 week low
0.00
low
50.59
growth
-32.31 %
previous Close
51.18
P/E ratio
46
market cap
3.64 B
div yield
0
usd
Jun 2025
qoq
revenue
321 M
-2.78 %
net incoming
34.03 M
-41.31 %
eps
1.10 %
-11.29 %
eps surprise
7.84 %
net profit margin
10.59 %
-6.00 %
operating incoming
55.14 M
-22.71 %
net change in cash
-13.87 M
1.55 %
cash on hand
293 M
-4.52 %
cost of revenue
141 M
2.46 %
top top